Certified by Founder
Lodge
DeepCure
start up
United States
- Boston, MA
- 08/11/2021
- Series A
- $40,000,000
DeepCure was founded to accelerate breakthrough science, developed by world-leading AI engineers, data scientists and biologists.
Our founding team includes some of the industry’s preeminent drug-discovery scientists and technologists.
Our vision is to use AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target.
- Industry Biotechnology Research
- Website https://deepcure.ai/
- LinkedIn https://www.linkedin.com/company/deepcure/about/
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)